Dusseldorf - Delayed Quote EUR
Novavax Inc (NVV1.DU)
6.33
+0.18
+(2.98%)
As of 8:10:38 AM GMT+2. Market Open.
Loading Chart for NVV1.DU
- Previous Close
6.14 - Open
0.00 - Bid 6.35 x --
- Ask 6.41 x --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 15.72 - Volume
0 - Avg. Volume
36 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: NVV1.DU
View MorePerformance Overview: NVV1.DU
Trailing total returns as of 6/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
NVV1.DU
19.37%
S&P 500 (^GSPC)
1.51%
1-Year Return
NVV1.DU
3.82%
S&P 500 (^GSPC)
12.83%
3-Year Return
NVV1.DU
3.82%
S&P 500 (^GSPC)
45.32%
5-Year Return
NVV1.DU
3.82%
S&P 500 (^GSPC)
91.83%
Compare To: NVV1.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
49.20
0.00%
Mkt Cap TWD 16.174B
Industry Biotechnology
Statistics: NVV1.DU
View MoreValuation Measures
As of 6/3/2025
Market Cap
1.03B
Enterprise Value
587.80M
Trailing P/E
2.56
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.94
Price/Book (mrq)
--
Enterprise Value/Revenue
0.55
Enterprise Value/EBITDA
1.21
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--